Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.55 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.49 |
| ▸ | PARP11 | Q9NR21 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 2/20 | 0.47 |
| ▸ | FLT3 | P36888 | 2/20 | 0.47 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.47 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 4/20 | 0.46 |
| ▸ | F9 | P00740 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 6/20 | 0.44 |
| ▸ | AURKA | O14965 | 2/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL618639 | 0.87 | CA12 (0.53) | CLK4DYRK1BMAOAMAOBNTRK1 | |
| M-Xylene SCHEMBL1785614 | 0.85 | CLK4 (0.55) | CLK4FYNDYRK1BPARP10PARP11 | |
| M-Xylene SCHEMBL1782272 | 0.83 | CLK4 (0.56) | CLK4FYNDYRK1BPARP10PARP11 | |
| M-Xylene SCHEMBL1788893 | 0.81 | CLK4 (0.51) | CLK4FYNDYRK1BPARP10PARP11 | |
| SCHEMBL148819 | 0.80 | PARP10 (0.68) | CLK4FYNDYRK1BPARP10PARP11 | |
| SCHEMBL13680532 | 0.80 | CLK4 (0.78) | CLK4FYNDYRK1BPARP10PARP11 | |
| SCHEMBL26775387 | 0.79 | CA9 (0.44) | CLK4DYRK1BMAOAMAOBNTRK1 | |
| SCHEMBL29853505 | 0.79 | CA9 (0.44) | CLK4DYRK1BMAOAMAOBNTRK1 | |
| Ethane SCHEMBL27832823 | 0.79 | PARP10 (0.66) | CLK4FYNDYRK1BPARP10PARP11 | |
| SCHEMBL26775540 | 0.74 | CLK4 (0.45) | CLK4FYNDYRK1BPARP10PARP11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10059666-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | PLASTIPAK PACKAGING, INC. (US) | 2018-08-28 | — | — | US | disclosed |
| US-20160311771-A1 | Oxygen Scavengers, Compositions Comprising the Scavengers, and Articles Made from the Compositions | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-10-27 | — | — | US | disclosed |
| US-9222020-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | PLASTIPAK PACKAGING, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-20130266752-A1 | Oxygen Scavengers, Compositions Comprising the Scavengers, and Articles Made from the Compositions | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2013-10-10 | — | — | US | disclosed |
| US-8450398-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | CONSTAR INTERNATIONAL, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| EP-2499134-A2 | OXYGEN SCAVENGERS, COMPOSITION COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | Constar International Inc. (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011060297-A2 | OXYGEN SCAVENGERS, COMPOSITION COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | CONSTAR INTERNATIONAL, INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110117301-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10059666-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | PRDX5, LPO, CAT | CLK4 4833/4885FYN 896/4885DYRK1B 4717/4885 |
| US-20110117301-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PRDX5, LPO, CAT | CLK4 4833/4885FYN 896/4885DYRK1B 4717/4885 |
| US-20160311771-A1 | Oxygen Scavengers, Compositions Comprising the Scavengers, and Articles Made from the Compositions | PRDX5, LPO, CAT | CLK4 4833/4885FYN 896/4885DYRK1B 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.